This investigation seeks to clarify the self-assembly process of CPBP, evaluate the translational prospects of CPBP nanoassemblies as a targeted therapeutic approach for infectious diseases (encompassing lung infection and skin wound infection), and examine the underlying mechanism of action. The gene discussed is KLF6; the disease is infectious disease.